China ready to take on the world

"Nowadays, Chinese pharmaceutical companies are capable of expanding their market worldwide, and Chinese medicine is capable of entering major Western markets, such as the U.S.," says Zhao Chao, president of Buchang Pharmaceuticals. "It's just a matter of how." Story

Suggested Articles

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.

Boehringer Ingelheim is investing $50 million in an animal health plant in Puerto Rico, adding 105 jobs.

Teva will begin producing chemo drug vincristine in the U.S. but has resisted the idea that its withdrawal from the market led to a shortage.